LMMY OTC
Exousia Bio, Inc.
1W: +5.6%
1M: -48.8%
3M: -96.1%
YTD: -95.5%
1Y: -90.6%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$4K
-67.4% ▼
Gross Profit
-$4K
-291.0% ▼
Operating Income
-$32K
-21.5% ▼
Net Income
$51K
+299.2% ▲
EPS (Diluted)
$0.01
+300.0% ▲
EBITDA
$55K
+578.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Revenue | $0 | $12K | $4K |
| YoY Growth | +0.0% | +0.0% | -67.4% |
| Cost of Revenue | $0 | $10K | $7K |
| Gross Profit | $0 | $2K | -$4K |
| Gross Margin | — | 15.9% | -93.4% |
| R&D Expenses | $0 | $0 | $0 |
| SG&A Expenses | $56K | $28K | $28K |
| Operating Expenses | $56K | $28K | $28K |
| Operating Income | $0 | -$26K | -$32K |
| Operating Margin | — | -228.2% | -850.2% |
| Interest Expense | $0 | $0 | $0 |
| Income Before Tax | -$56K | -$26K | $51K |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$56K | -$26K | $51K |
| Net Margin | — | -224.4% | 1370.5% |
| EPS (Diluted) | $-0.01 | $-0.00 | $0.01 |
| EBITDA | -$42K | -$12K | $55K |
| Shares Outstanding | 8M | 8M | 8M |